Study of Cytrix Use in Pelvic Floor Prolapse Treatment

Inclusion Criteria: * Female \>30 years of age * Willing and able to comply w/ the study procedures and provide written informed consent to participate in the study. * Diagnosed with pelvic organ prolapse with or without pelvis floor dysfunction * Patient is willing to complete PFDI-SF20 and PISQ-12 questionnaires at 6 and 12 months post-operatively * Patient is willing to answer phone questionnaires at 2 weeks, 6 weeks, and 3 months * Patients with a history of pelvic surgery (cystocele/anterior repair, hysterectomy, vault suspension, etc) prior to this procedure are allowed to participate in the study except if the patient had a dermal graft implanted. Exclusion Criteria: * Patients who, in the clinical judgment of the investigator, are not suitable for this study * Patients who are, in the Investigators opinion, mentally or legally incapacitated preventing informed consent or unable to read or understand written material. * Patients who have participated in an investigational study within 30 days of study entry that may impact analysis of this device or have previously participated in the current trial * Patient whose pelvic organ prolapse is Stage I * Patient with Diabetes Mellitus type I or II * Patient with morbid obesity (weight parameters determined by physician) * Patient with undiagnosed pelvic mass outside of the uterus (not expected to be functional in nature) * Patient with unexplained abnormal menstrual bleeding * Patient with any acute or chronic infection (kidney, bladder, lung, etc) * Patient with coagulopathy * Patient participating in other investigational device or drug study * Patients must not be pregnant * Patients with life expectancy less than 2 years * Patients with known or suspected hypersensitivity to collagen or bovine products * Patients with preexisting local or systemic infection * Patients with a history of soft tissue pathology where the implant is to be placed * Patients with any pathology that would limit the blood supply and compromise healing * Patient diagnosed with autoimmune connective tissue disease